Dr Richard Willis Runyan, MD | |
150 Vista Dr, Pocatello, ID 83201-5824 | |
(208) 232-7246 | |
Not Available |
Full Name | Dr Richard Willis Runyan |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 6 Years |
Location | 150 Vista Dr, Pocatello, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336482645 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 9169428-8905 (Utah) | Secondary |
207LP2900X | Anesthesiology - Pain Medicine | M-14202 (Idaho) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Signature Healthcare At Home Of S E Idaho | Chubbuck, ID | Home health agency |
Mountain View Hospital | Idaho falls, ID | Hospital |
Steele Memorial Medical Center | Salmon, ID | Hospital |
Portneuf Medical Center | Pocatello, ID | Hospital |
Bingham Memorial Hospital | Blackfoot, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mountain View Hospital Llc | 4486562774 | 176 |
News Archive
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Researchers from the University of Granada, who belong to the Brain, Mind and Behavior Research Center and the Faculty of Psychology, have proven that cortisol levels (a steroid hormone secreted as a response to stress) present in the hair of pregnant women during the first or third trimesters of pregnancy may indicate which of them are more likely to suffer postpartum depression.
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
› Verified 4 days ago
Entity Name | Mountain View Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669462362 PECOS PAC ID: 4486562774 Enrollment ID: O20040527001343 |
News Archive
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Researchers from the University of Granada, who belong to the Brain, Mind and Behavior Research Center and the Faculty of Psychology, have proven that cortisol levels (a steroid hormone secreted as a response to stress) present in the hair of pregnant women during the first or third trimesters of pregnancy may indicate which of them are more likely to suffer postpartum depression.
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
› Verified 4 days ago
Entity Name | Steele Memorial Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851403265 PECOS PAC ID: 9436131265 Enrollment ID: O20040604000056 |
News Archive
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Researchers from the University of Granada, who belong to the Brain, Mind and Behavior Research Center and the Faculty of Psychology, have proven that cortisol levels (a steroid hormone secreted as a response to stress) present in the hair of pregnant women during the first or third trimesters of pregnancy may indicate which of them are more likely to suffer postpartum depression.
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
› Verified 4 days ago
Entity Name | North Canyon Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609046671 PECOS PAC ID: 0941371439 Enrollment ID: O20090409000304 |
News Archive
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Researchers from the University of Granada, who belong to the Brain, Mind and Behavior Research Center and the Faculty of Psychology, have proven that cortisol levels (a steroid hormone secreted as a response to stress) present in the hair of pregnant women during the first or third trimesters of pregnancy may indicate which of them are more likely to suffer postpartum depression.
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
› Verified 4 days ago
Entity Name | Pain & Spine Consultants |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902366834 PECOS PAC ID: 5395072946 Enrollment ID: O20190806001323 |
News Archive
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Researchers from the University of Granada, who belong to the Brain, Mind and Behavior Research Center and the Faculty of Psychology, have proven that cortisol levels (a steroid hormone secreted as a response to stress) present in the hair of pregnant women during the first or third trimesters of pregnancy may indicate which of them are more likely to suffer postpartum depression.
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard Willis Runyan, MD 3385 Potomac Way, Idaho Falls, ID 83404-4978 Ph: () - | Dr Richard Willis Runyan, MD 150 Vista Dr, Pocatello, ID 83201-5824 Ph: (208) 232-7246 |
News Archive
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Researchers from the University of Granada, who belong to the Brain, Mind and Behavior Research Center and the Faculty of Psychology, have proven that cortisol levels (a steroid hormone secreted as a response to stress) present in the hair of pregnant women during the first or third trimesters of pregnancy may indicate which of them are more likely to suffer postpartum depression.
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
› Verified 4 days ago
Roger A Cook, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-1000 | |
Dr. Daniel Dalley Snell, M.D, M.P.H. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-232-7760 Fax: 208-232-1950 | |
Ryan R Shelton, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-1000 | |
Dr. John Benjamin Traul, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave Ste A, Pocatello, ID 83201 Phone: 208-232-7760 Fax: 208-232-1950 | |
Juan Jose Leon, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Portneuf Heart And Vascular, Pocatello, ID 83201 Phone: 208-239-2500 | |
Dr. Steven Larry Follett, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1749 Walkabout Dr, Pocatello, ID 83204 Phone: 208-241-4204 Fax: 208-234-1162 |